cooper development said revised results for year ended october loss mln dlrs dlrs per share down from previously reported loss mln dlrs cts per share restatement was made because change method accounting for combination several company controlled concerns resulted mln dlr charge cooper development said last august cooper development combined its cooper biomedical inc unit and its cooper laboratories subsidiary with technicon instruments corp company acquired from revlon inc cooper spokesman said spokesman said transaction was accounted for acquisition but securities and exchange commission took issue with accounting method and said should accounted for reorganization entities under common control this treatment requires costs associated with transaction expanded rather capitalized intangible asset company said also said since charged required expensing previously accrued liabilities company will experience resulting material change its cash flow reuter 